Distinguishing Pituitary Metastasis and Pituitary Neuroendocrine Tumors through Conventional MR Imaging and Clinical Features

References

1. 1.↵
   1. Kameda-Smith MM,
   2. Zhang E,
   3. Lannon M, et al

   . Pituitary metastasis: from pathology to clinical and radiological considerations. J Clin Neurosci 2021;93:231–40 doi:10.1016/j.jocn.2021.09.016 pmid:34656254

   CrossRefPubMed
2. 2.↵
   1. Marsh JC,
   2. Garg S,
   3. Wendt JA, et al

   . Intracranial metastatic disease rarely involves the pituitary: retrospective analysis of 935 metastases in 155 patients and review of the literature. Pituitary 2010;13:260–65 doi:10.1007/s11102-010-0229-4 pmid:20405323

   CrossRefPubMed
3. 3.↵
   1. Angelousi A,
   2. Alexandraki KI,
   3. Kyriakopoulos G, et al

   . Neoplastic metastases to the endocrine glands. Endocr Relat Cancer 2020;27:R1–20 doi:10.1530/ERC-19-0263 pmid:31645015

   CrossRefPubMed
4. 4.↵
   1. Habu M,
   2. Tokimura H,
   3. Hirano H, et al

   . Pituitary metastases: current practice in Japan. J Neurosurg 2015;123:998–1007 doi:10.3171/2014.12.JNS14870 pmid:26186025

   CrossRefPubMed
5. 5.↵
   1. Ng S,
   2. Fomekong F,
   3. Delabar V, et al

   . Current status and treatment modalities in metastases to the pituitary: a systematic review. J Neurooncol 2020;146:219–27 doi:10.1007/s11060-020-03396-w pmid:31933258

   CrossRefPubMed
6. 6.↵
   1. Karia K,
   2. Price SA,
   3. Soon WC, et al

   . Metastatic colon cancer in the pituitary: a case report with review of literature. Asian J Neurosurg 2021;16:872–75 doi:10.4103/ajns.AJNS_52_21 pmid:35071093

   CrossRefPubMed
7. 7.↵
   1. Javanbakht A,
   2. D'Apuzzo M,
   3. Badie B, et al

   . Pituitary metastasis: a rare condition. Endocr Connect 2018;7:1049–57 doi:10.1530/EC-18-0338 pmid:30139817

   Abstract
8. 8.↵
   1. Shimon I

   . Metastatic spread to the pituitary. Neuroendocrinology 2020;110:805–08 doi:10.1159/000506810 pmid:32101869

   CrossRefPubMed
9. 9.↵
   1. Barbaro D,
   2. Desogus N,
   3. Boni G

   . Pituitary metastasis of thyroid cancer. Endocrine 2013;43:485–93 doi:10.1007/s12020-012-9806-9 pmid:23008095

   CrossRefPubMed
10. 10.↵
    1. Cai H,
    2. Liu W,
    3. Feng T, et al

    . Clinical presentation and pathologic characteristics of pituitary metastasis from breast carcinoma: cases and a systematic review of the literature. World Neurosurg 2019;124:445–51.e2. doi:10.1016/j.wneu.2018.12.126 pmid:30630045

    CrossRefPubMed
11. 11.↵
    1. Benjamin C,
    2. Ashayeri K,
    3. Golfinos JG, et al

    . Treatment of sellar metastases with gamma knife radiosurgery in patients with advanced cancer. Pituitary 2020;23:665–71 doi:10.1007/s11102-020-01074-8 pmid:32860552

    CrossRefPubMed
12. 12.↵
    1. Abele TA,
    2. Yetkin ZF,
    3. Raisanen JM, et al

    . Non-pituitary origin sellar tumours mimicking pituitary macroadenomas. Clin Radiol 2012;67:821–27 doi:10.1016/j.crad.2012.01.001 pmid:22749386

    CrossRefPubMed
13. 13.↵
    1. Senetta R,
    2. Castellano I,
    3. Garbossa D, et al

    . Pituitary metastasis of an unknown neuroendocrine breast carcinoma mimicking a pituitary adenoma. Pathology 2013;45:422–24 doi:10.1097/PAT.0b013e328360dfd1 pmid:23635818

    CrossRefPubMed
14. 14.↵
    1. Dedeker C,
    2. Archibald H,
    3. Meares A, et al

    . Metastatic breast cancer masquerading as a pituitary macroadenoma: a case report. SAGE Open Med Case Rep 2022;10:2050313X211073243 doi:10.1177/2050313X211073243 pmid:35096396

    CrossRefPubMed
15. 15.↵
    1. Liu X,
    2. Wang R,
    3. Li M, et al

    . Pituitary metastasis of lung neuroendocrine carcinoma mimicking pituitary adenoma:case report and literature review. Front Endocrinol (Lausanne) 2021;12:678947 doi:10.3389/fendo.2021.678947 pmid:34335467

    CrossRefPubMed
16. 16.↵
    1. Goulart CR,
    2. Upadhyay S,
    3. Ditzel Filho LF, et al

    . Newly diagnosed sellar tumors in patients with cancer: a diagnostic challenge and management dilemma. World Neurosurg 2017;106:254–65 doi:10.1016/j.wneu.2017.06.139 pmid:28673886

    CrossRefPubMed
17. 17.↵
    1. Yang K,
    2. Begley SL,
    3. Lynch D, et al

    . Pituitary metastases: a case series and scoping review. Pituitary 2023;26:538–50 doi:10.1007/s11102-023-01349-w pmid:37698666

    CrossRefPubMed
18. 18.↵
    1. Sakai M,
    2. Kashiwagi N,
    3. Nakanishi K, et al

    . Nonbrain metastases seen on magnetic resonance imaging during metastatic brain tumor screening. Jpn J Radiol 2023;41:367–81 doi:10.1007/s11604-022-01362-2 pmid:36374473

    CrossRefPubMed
19. 19.↵
    1. Koutourousiou M,
    2. Kontogeorgos G,
    3. Seretis A

    . Non-adenomatous sellar lesions: experience of a single centre and review of the literature. Neurosurg Rev 2010;33:465–76 doi:10.1007/s10143-010-0263-8 pmid:20480381

    CrossRefPubMed
20. 20.↵
    1. Piedra MP,
    2. Brown PD,
    3. Carpenter PC, et al

    . Resolution of diabetes insipidus following gamma knife surgery for a solitary metastasis to the pituitary stalk: case report. J Neurosurg 2004;101:1053–56 doi:10.3171/jns.2004.101.6.1053 pmid:15597769

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Raverot G,
    2. Burman P,
    3. McCormack A, et al

    ; European Society of Endocrinology. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 2018;178:G1–24 doi:10.1530/EJE-17-0796 pmid:29046323

    Abstract/FREE Full Text
22. 22.↵
    1. Schill F,
    2. Nilsson M,
    3. Olsson DS, et al

    . Pituitary metastases: a nationwide study on current characteristics with special reference to breast cancer. J Clin Endocrinol Metab 2019;104:3379–88 doi:10.1210/jc.2019-00012 pmid:30892659

    CrossRefPubMed
23. 23.↵
    1. Kim YH,
    2. Lee BJ,
    3. Lee KJ, et al

    . A case of pituitary metastasis from breast cancer that presented as left visual disturbance. J Korean Neurosurg Soc 2012;51:94–97 doi:10.3340/jkns.2012.51.2.94 pmid:22500201

    CrossRefPubMed
24. 24.↵
    1. Altshuler DB,
    2. Andrews CA,
    3. Parmar HA, et al

    . Imaging errors in distinguishing pituitary adenomas from other sellar lesions. J Neuroophthalmol 2021;41:512–18 doi:10.1097/WNO.0000000000001164 pmid:33630780

    CrossRefPubMed
25. 25.↵
    1. Knosp E,
    2. Steiner E,
    3. Kitz K, et al

    . Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993;33:610–18 doi:10.1227/00006123-199310000-00008 pmid:8232800

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Liu CX,
    2. Wang SZ,
    3. Heng LJ, et al

    . Predicting subtype of growth hormone pituitary adenoma based on magnetic resonance imaging characteristics. J Comput Assist Tomogr 2022;46:124–30 doi:10.1097/RCT.0000000000001249 pmid:35099144

    CrossRefPubMed
27. 27.↵
    1. Bursac Z,
    2. Gauss CH,
    3. Williams DK, et al

    . Purposeful selection of variables in logistic regression. Source Code Biol Med 2008;3:17 doi:10.1186/1751-0473-3-17 pmid:19087314

    CrossRefPubMed
28. 28.↵
    1. Hong S,
    2. Atkinson JL,
    3. Erickson D, et al

    . Contemporary treatment outcome of metastases to the pituitary gland. World Neurosurg 2023;172:e684–94 doi:10.1016/j.wneu.2023.02.002 pmid:36764447

    CrossRefPubMed